Device Trial Radar · NCT03385187
Prospective Validation Study of a Novel Type IV Home Sleep Apnea Test
Last checked: Nov 19, 2026Latest source record: Mar 21, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
450
Planned (sponsor's estimate)
Start
Jun 29, 2017
Primary completion
Sep 15, 2019
Study completion Dec 15, 2019
Sponsor
- Lead sponsor
- Ectosense NVNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Ziekenhuis Oost-Limburg
- First posted
- Dec 28, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Prospective validation study of the NightOwl, a Type IV home sleep apnea test (HSAT), compared to a traditional Type I and a Type IV sleep monitor.
Conditions
- Sleep Apnea
Interventions
NightOwl HSATDevice
Patient wears the NightOwl sensor device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Apnea-Hypopnea Index (AHI)Time frame: At the time of the diagnostic night
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.